J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text PDF] （in Japanese / 1250KB） [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 86(9): 1112-1115, 1985

Report on the annual meeting

IMMUNE DEFENSE SYSTEM IN GASTRIC CANCER TISSUE, REGIONAL LYMPH NODE AND SPLEEN
ーASPECTS FROM SUBSETS AND FUNCTIONS OF LYMPHOCYTESー

First Department of Surgery, Okayama University Medical School, Okayama, Japan

Noriaki Tanaka, Akira Gohchi, Yoshikazu Akura, Kiyotoshi Gotoh, Takahiro Okabayashi, Tadashi Horimi, Kunzo Orita

Tumor infiltrating lymphocytes (TIL) and lymph node lymphocytes (LNL) were thought to play an important role in local immunity against cancer. But the natural cytotoxicity (NC) of TIL and LNL was very weak, and was not augmented by β-IFN. This low cytotoxicity was augmented by IL-2, and especially LNL were activated to have higher lymphokine activated killer (LAK) activity than that of PBL. So it was proven that TIL and LNL had an potential of immunological defence system.
In order to bring out these potential, immunomodulators (OK-432, PSK) were injected intralesionally under endoscopy one week prior to surgery. The cytotoxicity of TIL and LNL was augmented by the intralesional injection of OK-432 or PSK. There was no significant difference in LAK activity of LNL among the OK-432-, PSK-injected group, and the control. The 2-year survival rate of the OK-432-injected group was much longer than that of the control.
From above results, intralesional injection of immunomodulators was thought to be a promising candidate for the immunotherapy of gastric cancer.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.